Lilly's Kwikpen debut intensifies rivalry with Novo Nordisk's Wegovy in the world's most populous diabetes market ...

Eli Lilly has launched Mounjaro in KwikPen, a prefilled pen for weekly administration, in India to treat type 2 diabetes and ...

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant ...

Eli Lilly (LLY) stock in focus as the company launches Mounjaro Kwikpen in India, intensifying competition with Novo ...

Eli Lilly launches Mounjaro KwikPen in India, offering adults with type 2 diabetes and obesity a once-weekly, ...

The Mounjaro KwikPen, a multi-dose, prefilled device for single-patient use, is designed for convenient self-administration.

Eli Lilly has launched pre-filled injector pens of its blockbuster weight-loss drug, Mounjaro, giving more options for those ...

Each KwikPen contains four doses, designed for single-patient use, and is priced between Rs14,000 and Rs 27,500 per month ...

Eli Lilly’s obesity drug Mounjaro (tirzepatide) will launch in Korea next week, offering a 25 percent discount compared to ...

Eli Lilly Korea is set to launch its obesity drug Mounjaro (ingredient: tirzepatide) in Korea in mid-August, with the product priced about 25 percent lower than rival drug Wegovy, Korean news agency N ...

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...

[엠투데이 임헌섭 기자] 체중 감량 치료제 젭바운드(Zepbound)와 마운자로(Mounjaro) 제조사인 일라이 릴리(Eli Lilly and Company)가 새로운 먹는 비만약 ...